JAZZ
Price
$167.03
Change
-$0.07 (-0.04%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
10.15B
89 days until earnings call
Intraday BUY SELL Signals
NUVL
Price
$106.81
Change
-$0.09 (-0.08%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
8.3B
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

JAZZ vs NUVL

Header iconJAZZ vs NUVL Comparison
Open Charts JAZZ vs NUVLBanner chart's image
Jazz Pharmaceuticals
Price$167.03
Change-$0.07 (-0.04%)
Volume$10.55K
Capitalization10.15B
Nuvalent
Price$106.81
Change-$0.09 (-0.08%)
Volume$8.75K
Capitalization8.3B
JAZZ vs NUVL Comparison Chart in %
JAZZ
Daily Signal:
Gain/Loss:
NUVL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
JAZZ vs. NUVL commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAZZ is a Hold and NUVL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (JAZZ: $167.10 vs. NUVL: $106.90)
Brand notoriety: JAZZ and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAZZ: 87% vs. NUVL: 71%
Market capitalization -- JAZZ: $10.15B vs. NUVL: $8.3B
JAZZ [@Biotechnology] is valued at $10.15B. NUVL’s [@Biotechnology] market capitalization is $8.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAZZ’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • JAZZ’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAZZ’s TA Score shows that 3 TA indicator(s) are bullish while NUVL’s TA Score has 3 bullish TA indicator(s).

  • JAZZ’s TA Score: 3 bullish, 5 bearish.
  • NUVL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than NUVL.

Price Growth

JAZZ (@Biotechnology) experienced а -5.55% price change this week, while NUVL (@Biotechnology) price change was -1.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

JAZZ is expected to report earnings on Mar 03, 2026.

NUVL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($10.2B) has a higher market cap than NUVL($8.3B). NUVL (36.561) and JAZZ (35.688) have similar YTD gains . JAZZ has higher annual earnings (EBITDA): 372M vs. NUVL (-362.01M). JAZZ has more cash in the bank: 1.67B vs. NUVL (1.01B). JAZZ has higher revenues than NUVL: JAZZ (4.09B) vs NUVL (0).
JAZZNUVLJAZZ / NUVL
Capitalization10.2B8.3B123%
EBITDA372M-362.01M-103%
Gain YTD35.68836.56198%
P/E Ratio15.38N/A-
Revenue4.09B0-
Total Cash1.67B1.01B166%
Total Debt5.43BN/A-
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JAZZNUVL
RSI
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 11 days ago
60%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
57%
Bearish Trend 25 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
JAZZ
Daily Signal:
Gain/Loss:
NUVL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TYD26.290.16
+0.61%
Direxion Daily 7-10 Yr Trs Bull 3X ETF
RIFR26.170.07
+0.28%
Russell Inv Global Infrastructure ETF
BBN17.300.02
+0.12%
BlackRock Taxable Municipal
NBTR50.88N/A
N/A
Neuberger Berman Total Return Bond ETF
TBT33.73-0.20
-0.59%
ProShares UltraShort 20+ Year Treasury

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with AMLX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
+0.23%
AMLX - JAZZ
43%
Loosely correlated
+3.35%
ZYME - JAZZ
43%
Loosely correlated
+4.46%
BMRN - JAZZ
42%
Loosely correlated
+0.78%
NUVL - JAZZ
35%
Loosely correlated
+1.85%
XNCR - JAZZ
35%
Loosely correlated
+8.26%
More

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with XNCR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+1.85%
XNCR - NUVL
60%
Loosely correlated
+8.26%
RVMD - NUVL
59%
Loosely correlated
+3.16%
IDYA - NUVL
58%
Loosely correlated
+1.93%
XENE - NUVL
58%
Loosely correlated
+3.29%
VRDN - NUVL
56%
Loosely correlated
+2.86%
More